Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?

Simple item page
dc.contributor.authorPaul, Sourabhen_US
dc.contributor.authorSeth, Aswani Kumaren_US
dc.contributor.authorPawar, Neerajen_US
dc.contributor.authorSingh, Abhayen_US
dc.contributor.authorShukla, Mukeshen_US
dc.contributor.authorNath, Bholaen_US
dc.date.accessioned2025-08-13T09:35:50Z
dc.date.available2025-08-13T09:35:50Z
dc.date.issued2025-06
dc.description.abstractBackground & objectives: There is a persistent high microfilaria rate and variable reporting of coverage of Mass Drug Administration (MDA). This study aims to estimate the coverage, effective coverage, and compliance of drugs administered under MDA and determine the predictors affecting effective coverage. Methods: A community-based cross-sectional study was conducted in Amethi, Lucknow, Raebareli and Sultanpur districts of Uttar Pradesh, India. The study participants were selected using multi-stage random sampling using Probability Proportional to Estimated Size (PPES). The coverage, effective coverage and compliance of drugs were presented as proportion. The multivariable logistic regression model was applied to identify the significant predictors for effective coverage. Results: Of 4151 participants, 997 (24.0%), 340 (8.2%), 1158 (27.9%) and 1656 (39.9%) belonged to Amethi, Lucknow, Raebareli and Sultanpur districts, respectively. The coverage ranged from 49.8% to 87.9% and effective coverage ranged from 51.8% to 73.2% across districts. The compliance was the poorest (70.7%) in Sultanpur. The source of information about MDA, gender of the study participants and area of residence emerged as predictors for effective coverage in the districts. Interpretation & conclusion: The effective coverage was poor with good drug compliance across the districts. There is a need for a well-designed pre-MDA campaign addressing the fear of side effects of drugs and emphasizing the presence of the community during the MDA round along with monitoring and evaluation of the round.en_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.affiliationsDepartment of Community Medicine, All India Institute of Medical Sciences, Raebareli, Indiaen_US
dc.identifier.citationPaul Sourabh, Seth Aswani Kumar, Pawar Neeraj, Singh Abhay, Shukla Mukesh, Nath Bhola. Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?. Journal of Vector Borne Diseases . 2025 Jun; 62(2): 172-180en_US
dc.identifier.issn0972-9062
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/252550
dc.languageenen_US
dc.publisherWolters Kluwer – Medknowen_US
dc.relation.issuenumber2en_US
dc.relation.volume62en_US
dc.source.urihttps://doi.org/10.4103/JVBD.JVBD_102_24https://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.subjectComplianceen_US
dc.subjectEffective coverageen_US
dc.subjectEndemicen_US
dc.subjectLymphatic filariasisen_US
dc.subjectMass Drug Administrationen_US
dc.titleCoverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JVBD2025v62n2p172.pdf
Size:
433.12 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Vector Borne Diseases